CNVVY
Price
$12.90
Change
+$0.06 (+0.47%)
Updated
Sep 4 closing price
Capitalization
6.53B
68 days until earnings call
DSRLF
Price
$100.00
Change
-$7.68 (-7.13%)
Updated
Aug 21 closing price
Capitalization
5.19B
Interact to see
Advertisement

CNVVY vs DSRLF

Header iconCNVVY vs DSRLF Comparison
Open Charts CNVVY vs DSRLFBanner chart's image
ConvaTec Group
Price$12.90
Change+$0.06 (+0.47%)
Volume$11.84K
Capitalization6.53B
Diasorin S.R.L
Price$100.00
Change-$7.68 (-7.13%)
Volume$160
Capitalization5.19B
CNVVY vs DSRLF Comparison Chart in %
Loading...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNVVY vs. DSRLF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNVVY is a Buy and DSRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CNVVY: $12.90 vs. DSRLF: $100.00)
Brand notoriety: CNVVY and DSRLF are both not notable
CNVVY represents the Pharmaceuticals: Other, while DSRLF is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CNVVY: 13% vs. DSRLF: 95%
Market capitalization -- CNVVY: $6.53B vs. DSRLF: $5.35B
CNVVY [@Pharmaceuticals: Other] is valued at $6.53B. DSRLF’s [@Medical Specialties] market capitalization is $5.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical Specialties] industry is $10.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNVVY’s FA Score shows that 1 FA rating(s) are green whileDSRLF’s FA Score has 1 green FA rating(s).

  • CNVVY’s FA Score: 1 green, 4 red.
  • DSRLF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNVVY and DSRLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNVVY’s TA Score shows that 4 TA indicator(s) are bullish while DSRLF’s TA Score has 1 bullish TA indicator(s).

  • CNVVY’s TA Score: 4 bullish, 3 bearish.
  • DSRLF’s TA Score: 1 bullish, 4 bearish.
According to our system of comparison, CNVVY is a better buy in the short-term than DSRLF.

Price Growth

CNVVY (@Pharmaceuticals: Other) experienced а +0.62% price change this week, while DSRLF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.22%. For the same industry, the average monthly price growth was +6.83%, and the average quarterly price growth was +11.96%.

Reported Earning Dates

CNVVY is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNVVY($6.53B) has a higher market cap than DSRLF($5.19B). CNVVY has higher P/E ratio than DSRLF: CNVVY (30.57) vs DSRLF (24.74). CNVVY YTD gains are higher at: 14.959 vs. DSRLF (-6.415). DSRLF has more cash in the bank: 174M vs. CNVVY (56.8M). DSRLF has less debt than CNVVY: DSRLF (769M) vs CNVVY (1.34B).
CNVVYDSRLFCNVVY / DSRLF
Capitalization6.53B5.19B126%
EBITDAN/A406M-
Gain YTD14.959-6.415-233%
P/E Ratio30.5724.74124%
RevenueN/A1.22B-
Total Cash56.8M174M33%
Total Debt1.34B769M174%
FUNDAMENTALS RATINGS
CNVVY vs DSRLF: Fundamental Ratings
CNVVY
DSRLF
OUTLOOK RATING
1..100
596
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
8663
PRICE GROWTH RATING
1..100
6162
P/E GROWTH RATING
1..100
8272
SEASONALITY SCORE
1..100
906

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DSRLF's Valuation (9) in the null industry is in the same range as CNVVY (23). This means that DSRLF’s stock grew similarly to CNVVY’s over the last 12 months.

CNVVY's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for DSRLF (100). This means that CNVVY’s stock grew somewhat faster than DSRLF’s over the last 12 months.

DSRLF's SMR Rating (63) in the null industry is in the same range as CNVVY (86). This means that DSRLF’s stock grew similarly to CNVVY’s over the last 12 months.

CNVVY's Price Growth Rating (61) in the null industry is in the same range as DSRLF (62). This means that CNVVY’s stock grew similarly to DSRLF’s over the last 12 months.

DSRLF's P/E Growth Rating (72) in the null industry is in the same range as CNVVY (82). This means that DSRLF’s stock grew similarly to CNVVY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNVVYDSRLF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
21%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
33%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
57%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
46%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
52%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WAR23.470.17
+0.73%
U.S. Global Technology and Aerospace and Defense ETF
IBDU23.450.07
+0.30%
iShares iBonds Dec 2029 Term Corp ETF
PHYL35.550.07
+0.20%
PGIM Active High Yield Bond ETF
AMJB30.260.04
+0.13%
Alerian MLP Index ETN
GHMS26.08N/A
N/A
Goose Hollow Multi-Strategy Income ETF

CNVVY and

Correlation & Price change

A.I.dvisor tells us that CNVVY and ALGN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNVVY and ALGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
+0.47%
ALGN - CNVVY
27%
Poorly correlated
+1.77%
SGHT - CNVVY
25%
Poorly correlated
-1.84%
RVTY - CNVVY
24%
Poorly correlated
+2.81%
KIDS - CNVVY
22%
Poorly correlated
-0.91%
CRL - CNVVY
21%
Poorly correlated
-0.01%
More

DSRLF and

Correlation & Price change

A.I.dvisor tells us that DSRLF and TWST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DSRLF and TWST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSRLF
1D Price
Change %
DSRLF100%
N/A
TWST - DSRLF
28%
Poorly correlated
-1.42%
LMAT - DSRLF
26%
Poorly correlated
+2.65%
LUNG - DSRLF
21%
Poorly correlated
+4.82%
AVCRF - DSRLF
20%
Poorly correlated
-2.50%
CNVVY - DSRLF
16%
Poorly correlated
+0.47%
More